irsogladine has been researched along with Esophageal Reflux in 1 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
| Excerpt | Relevance | Reference |
|---|---|---|
| "The addition of IM to rabeprazole significantly improves gastroesophageal reflux disease symptoms and the quality of the lives of patients with NERD grade N." | 5.20 | Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study. ( Igarashi, M; Imai, J; Koike, J; Masui, A; Matsushima, M; Mine, T; Nakamura, J; Suzuki, T; Tsuda, S; Tsukune, Y; Uchida, T; Yuhara, H, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, T | 1 |
| Matsushima, M | 1 |
| Masui, A | 1 |
| Tsuda, S | 1 |
| Imai, J | 1 |
| Nakamura, J | 1 |
| Tsukune, Y | 1 |
| Uchida, T | 1 |
| Yuhara, H | 1 |
| Igarashi, M | 1 |
| Koike, J | 1 |
| Mine, T | 1 |
1 trial available for irsogladine and Esophageal Reflux
| Article | Year |
|---|---|
Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.
Topics: Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Female; Gastroesopha | 2015 |